Kohjin Bio Co., Ltd.
177A | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 坂戸市千代田５−１−３
- Website:
- https://kohjin-bio.jp/en/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Kohjin Bio Co., Ltd. is a pioneering Japanese biotechnology company dedicated to advancing regenerative medicine. Originating from the breeding and management of laboratory animals, Kohjin Bio has expanded its expertise to manufacture and sell animal blood, serum, and various immunological products. The company serves as a vital supply base for both polychrome and monochrome raw materials, while also developing specialized media for microbial testing and tissue culture. Committed to innovation, Kohjin Bio collaborates with medical institutions to process and deliver cells used in cancer immune cell therapy. As an organized group of thinkers, Kohjin Bio continues to shape the future of biotechnology through its diverse offerings and commitment to new creations.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-27 08:30 |
Inside Information Statement
臨時報告書
|
Japanese | 23.8 KB | |
| 2025-06-24 09:09 |
Internal Control over Financial Reporting
内部統制報告書－第44期(2024/04/01－2025/03/31)
|
Japanese | 25.0 KB | |
| 2025-06-24 09:08 |
Regulatory News Service
確認書
|
Japanese | 9.0 KB | |
| 2025-06-24 09:06 |
Annual Report
有価証券報告書－第44期(2024/04/01－2025/03/31)
|
Japanese | 1.8 MB | |
| 2024-11-14 07:30 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2024-11-14 07:30 |
Interim Report
半期報告書－第44期(2024/04/01－2025/03/31)
|
Japanese | 200.4 KB | |
| 2024-07-04 02:15 |
Inside Information Statement
臨時報告書
|
Japanese | 27.7 KB | |
| 2024-06-28 08:09 |
Regulatory News Service
確認書
|
Japanese | 9.0 KB | |
| 2024-06-28 08:00 |
Annual Report
有価証券報告書－第43期(2023/04/01－2024/03/31)
|
Japanese | 1.7 MB | |
| 2024-04-25 05:44 |
Inside Information Statement
臨時報告書
|
Japanese | 21.2 KB | |
| 2024-04-16 08:01 |
Regulatory News Service
訂正有価証券届出書（新規公開時）
|
Japanese | 1.8 MB | |
| 2024-04-08 03:00 |
Regulatory News Service
訂正有価証券届出書（新規公開時）
|
Japanese | 1.8 MB | |
| 2024-03-22 07:00 |
Prospectus
有価証券届出書（新規公開時）
|
Japanese | 3.5 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Nippon Shinyaku Co.,Ltd. | Japan | 4516 | |
|
Noile-Immune Biotech Inc. | Japan | 4893 | |
|
Novartis AG | Switzerland | NOVN | |
|
Nur Ink Innovations Ltd. | Israel | NURI | |
|
Nxera Pharma Co., Ltd. | Japan | 4565 | |
|
ObsEva SA | Switzerland | OBSN | |
|
ODI Pharma AB | Sweden | ODI | |
|
Oncolys BioPharma Inc. | Japan | 4588 | |
|
OncoTherapy Science, Inc. | Japan | 4564 | |
|
OncoZenge AB | Sweden | ONCOZ |